People are buying what they believe to be retatrutide from WhatsApp groups, Chinese labs and websites selling it “for ...

The White House recently endorsed monitoring sewage for evidence of drug use. Critics fear such efforts could violate privacy ...

For years, overdose deaths in North Carolina have been falling, part of a broader national trend that researchers say is being driven in part by better information, stronger community partnerships, ...

CHICAGO (WLS) -- A prominent lab used by prosecutors for marijuana DUI testing in Chicago and the suburbs is no longer doing human testing but the fallout surrounding the flawed results continues.

Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in a cancer-related protein that could open the door toward the development of a new ...

DES MOINES, Iowa (KCRG) - Iowans will get a chunk of a $4.9 million multi-state settlement from a lab overcharging for COVID tests, Attorney General Brenna Bird announced Wednesday. GS Labs was ...

Health officials in British Columbia are warning drug users about a new laboratory-made opioid that's made its way into the unregulated drug supply in the province. Last week, Interior Health issued a ...

Add Yahoo as a preferred source to see more of our stories on Google. A recent sample of down in Penticton, B.C., was found to contain cychlorphine, a relatively new lab-created opioid. (Interior ...

Both models trade word-by-word generation for parallel denoising. Only one of them does it without losing intelligence in the ...

If you explore off the beaten track, you'll find plenty of 007 First Light safe codes. The problem is, some of them are trickier to unlock than others. Most safes are optional, but unlocking them will ...

WASHINGTON (7News) — For more than two years, we've been investigating questions about the safety of some foreign-manufactured generic drugs used by tens of millions of Americans. This week, those ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...